Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen

Cell-targeted therapies (smart drugs), which selectively control cancer cell progression with limited toxicity to normal cells, have been developed to effectively treat some cancers. However, many cancers such as metastatic prostate cancer (PC) have yet to be treated with current smart drug technolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dassie, Justin P, Hernandez, Luiza I, Thomas, Gregory S, Long, Matthew E, Rockey, William M, Howell, Craig A, Chen, Yani, Hernandez, Frank J, Liu, Xiu Ying, Wilson, Mary E, Allen, Lee-Ann, Vaena, Daniel A, Meyerholz, David K, Giangrande, Paloma H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429728/
https://www.ncbi.nlm.nih.gov/pubmed/24954476
http://dx.doi.org/10.1038/mt.2014.117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429728/
https://www.ncbi.nlm.nih.gov/pubmed/24954476
http://dx.doi.org/10.1038/mt.2014.117

Ejemplares similares